Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,A1BG,Alpha-1B-glycoprotein,1513,38,9.89 [1.70-57.60],0.0108026167824936
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",1483,38,1.52 [1.06-2.17],0.0223151459065991
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACTA2,"Actin, aortic smooth muscle",1701,48,1.73 [1.22-2.46],0.0022794563574411
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ACVRL1,Serine/threonine-protein kinase receptor R3,1715,47,5.69 [2.76-11.75],2.585420170149092e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADA2,Adenosine deaminase 2,1728,48,2.06 [1.24-3.40],0.0050389098072625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,1453,37,2.15 [1.10-4.20],0.0251966619923
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,1718,47,2.30 [1.17-4.51],0.0156498889543559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,1487,38,2.89 [1.37-6.09],0.0053230416746457
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,1453,37,4.36 [2.04-9.33],0.0001450841477588
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADAMTSL2,ADAMTS-like protein 2,1508,38,1.94 [1.04-3.63],0.0371756869795076
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRB3,Adhesion G protein-coupled receptor B3,1715,47,2.62 [1.55-4.44],0.00033847000632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRD1,Adhesion G-protein coupled receptor D1,1479,37,3.06 [1.61-5.81],0.0006536854120295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRF5,Adhesion G protein-coupled receptor F5,1502,38,3.63 [1.19-11.08],0.0238968152344174
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG1,Adhesion G-protein coupled receptor G1,1733,49,1.47 [1.19-1.81],0.0003774938711404
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADGRG2,Adhesion G-protein coupled receptor G2,1735,50,0.41 [0.17-0.97],0.043401744879656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ADM,Pro-adrenomedullin,1751,50,8.77 [3.34-22.99],1.0164943334106428e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR2,Anterior gradient protein 2 homolog,1659,43,1.64 [1.30-2.08],4.069462790485162e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGR3,Anterior gradient protein 3,1680,45,2.22 [1.44-3.43],0.0003386115965743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRN,Agrin,1738,49,2.65 [1.58-4.44],0.0002233247090238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AGRP,Agouti-related protein,1751,50,1.64 [1.04-2.59],0.0342280374947424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMBP,Protein AMBP,1749,50,11.19 [3.95-31.72],5.590195528753174e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AMY2B,Alpha-amylase 2B,1598,47,0.61 [0.37-1.00],0.0483300047109783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANG,Angiogenin,1736,48,2.03 [1.08-3.81],0.028135832955376
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPT2,Angiopoietin-2,1751,50,3.07 [1.76-5.34],7.295014624514548e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ANGPTL4,Angiopoietin-related protein 4,1733,49,3.14 [1.90-5.20],8.320980083069513e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AOC3,Membrane primary amine oxidase,1743,49,3.08 [1.47-6.44],0.0028223762150658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,1733,49,1.62 [1.06-2.47],0.0260944522280698
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOA4,Apolipoprotein A-IV,1513,38,2.91 [1.55-5.47],0.0009312881107664
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOF,Apolipoprotein F,1511,38,0.41 [0.18-0.91],0.0280085430949101
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,APOH,Beta-2-glycoprotein 1,1741,50,1.97 [1.04-3.72],0.0370211419746067
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,AREG,Amphiregulin,1733,49,1.86 [1.21-2.88],0.0050606930791136
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR1,Asialoglycoprotein receptor 1,1718,47,3.40 [1.76-6.56],0.0002697257646216
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASGR2,Asialoglycoprotein receptor 2,1511,38,4.65 [2.00-10.77],0.0003432305168994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ASPN,Asporin,1502,38,2.25 [1.18-4.29],0.014346901956814
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ATRAID,All-trans retinoic acid-induced differentiation factor,1487,38,2.15 [1.08-4.27],0.0297353392707282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B2M,Beta-2-microglobulin,1513,38,2.57 [1.23-5.36],0.012183849979103
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",1469,38,4.00 [1.80-8.91],0.0006836226546176
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,1682,45,1.60 [1.16-2.22],0.0044868712766554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BCAM,Basal cell adhesion molecule,1741,50,2.88 [1.13-7.33],0.0261124708126068
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMP10,Bone morphogenetic protein 10,1479,37,7.84 [2.75-22.34],0.0001178580265819
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BMPER,BMP-binding endothelial regulator protein,1479,37,4.99 [1.48-16.91],0.0097458230631279
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BOC,Brother of CDO,1701,48,2.95 [1.02-8.50],0.0452381034180111
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BSG,Basigin,1749,50,3.70 [1.35-10.17],0.011058410263675
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN2A1,Butyrophilin subfamily 2 member A1,1738,49,3.67 [2.00-6.71],2.4611294251847167e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,BTN3A2,Butyrophilin subfamily 3 member A2,1726,49,2.14 [1.14-4.02],0.0177143218579797
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1GALT1C1,C1GALT1-specific chaperone 1,1448,37,3.58 [1.56-8.22],0.0026315865260561
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,1743,49,1.67 [1.01-2.75],0.0446575214466123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,1506,38,1.78 [1.03-3.10],0.0392561815777699
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA12,Carbonic anhydrase 12,1733,49,3.03 [2.13-4.31],7.288860695101504e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CA4,Carbonic anhydrase 4,1753,50,2.60 [1.10-6.17],0.0302239351830086
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB1,Calbindin,1733,49,2.29 [1.36-3.85],0.0018507808523271
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CALB2,Calretinin,1670,45,2.49 [1.21-5.15],0.0134963478218238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLIF,Cobalamin binding intrinsic factor,1735,50,1.36 [1.03-1.80],0.0289409243434602
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CBLN4,Cerebellin-4,1751,50,0.35 [0.17-0.70],0.0029749255891106
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCDC80,Coiled-coil domain-containing protein 80,1735,50,2.01 [1.18-3.40],0.009676448791816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL14,C-C motif chemokine 14,1736,48,2.47 [1.42-4.30],0.0013707865863123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL15,C-C motif chemokine 15,1753,50,1.99 [1.25-3.16],0.0035342623437123
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL16,C-C motif chemokine 16,1753,50,1.69 [1.08-2.65],0.0223217596700571
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL25,C-C motif chemokine 25,1751,50,2.27 [1.35-3.81],0.0019540672220689
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCL3,C-C motif chemokine 3,1726,49,1.31 [1.03-1.67],0.0259856830238798
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN3,CCN family member 3,1745,50,3.28 [1.99-5.41],3.3555374233456667e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN4,CCN family member 4,1751,50,2.42 [1.42-4.12],0.0011453902486198
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CCN5,CCN family member 5,1741,50,3.05 [1.85-5.04],1.2998340911257011e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD160,CD160 antigen,1751,50,2.02 [1.25-3.26],0.0039398709803267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD164,Sialomucin core protein 24,1741,50,1.51 [1.05-2.15],0.0246274254044835
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD207,C-type lectin domain family 4 member K,1710,49,2.57 [1.45-4.57],0.0012505861153635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD27,CD27 antigen,1741,50,3.05 [1.99-4.66],2.730361118556368e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD276,CD276 antigen,1726,49,3.24 [1.94-5.41],7.626223405304471e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300C,CMRF35-like molecule 6,1748,49,3.63 [1.90-6.93],9.484686037623414e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300E,CMRF35-like molecule 2,1744,50,2.04 [1.21-3.45],0.0076311205238041
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD300LG,CMRF35-like molecule 9,1741,50,2.67 [1.52-4.70],0.000616231680978
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD302,CD302 antigen,1733,49,3.43 [1.84-6.37],9.987463294181751e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,1733,49,2.54 [1.33-4.84],0.0047519155496747
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD5,T-cell surface glycoprotein CD5,1749,50,2.44 [1.24-4.80],0.010155996769783
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD55,Complement decay-accelerating factor,1669,47,3.42 [1.63-7.19],0.0011328656434273
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD59,CD59 glycoprotein,1670,50,3.55 [1.63-7.72],0.0014116249275146
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD74,HLA class II histocompatibility antigen gamma chain,1748,49,3.96 [2.13-7.39],1.4739012950186697e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD79B,B-cell antigen receptor complex-associated protein beta chain,1751,50,1.67 [1.05-2.66],0.031513540614686
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD80,T-lymphocyte activation antigen CD80,1502,38,2.44 [1.21-4.91],0.0122271661073208
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD83,CD83 antigen,1726,49,2.24 [1.23-4.10],0.0084817278610807
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CD93,Complement component C1q receptor,1667,42,2.19 [1.04-4.60],0.0386595975186645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH1,Cadherin-1,1667,47,1.94 [1.28-2.94],0.0016926318590861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH15,Cadherin-15,1744,49,1.66 [1.19-2.32],0.002910960047597
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDH3,Cadherin-3,1748,49,2.39 [1.35-4.24],0.0028565575607181
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDNF,Cerebral dopamine neurotrophic factor,1733,49,2.31 [1.19-4.50],0.0136185855270072
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,1730,49,3.24 [1.31-7.97],0.0106472564412503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CDSN,Corneodesmosin,1742,50,1.86 [1.10-3.14],0.0207903700177535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,1483,38,1.33 [1.00-1.77],0.0471616754935046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEBPB,CCAAT/enhancer-binding protein beta,1701,48,0.41 [0.19-0.86],0.0177263228486038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,1479,37,2.82 [1.07-7.43],0.0365375524495455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CEP350,Centrosome-associated protein 350,1449,38,1.57 [1.07-2.28],0.0196380934308702
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CES2,Cocaine esterase,1733,49,1.86 [1.27-2.72],0.001418097531225
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CFC1,Cryptic protein,1682,45,1.57 [1.06-2.31],0.0236414831493267
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CGREF1,Cell growth regulator with EF hand domain protein 1,1735,50,3.08 [2.02-4.69],1.873332043643526e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHAD,Chondroadherin,1479,37,0.53 [0.31-0.91],0.0206278009242746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",1497,38,2.94 [1.66-5.22],0.0002317298100768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHCHD6,MICOS complex subunit MIC25,1498,38,2.03 [1.05-3.94],0.035718156471877
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGA,Chromogranin-A,1508,38,1.30 [1.05-1.60],0.0169961455392546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHGB,Secretogranin-1,1741,49,2.48 [1.60-3.84],4.963852590140754e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHI3L1,Chitinase-3-like protein 1,1690,47,1.64 [1.25-2.16],0.0003742177078595
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CHRDL1,Chordin-like protein 1,1733,49,3.43 [1.72-6.83],0.0004741991888081
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKAP4,Cytoskeleton-associated protein 4,1745,50,3.85 [2.19-6.78],3.0271303737463565e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CKB,Creatine kinase B-type,1508,38,1.81 [1.21-2.72],0.0040345725103908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC10A,C-type lectin domain family 10 member A,1718,47,2.76 [1.32-5.77],0.0070216578933309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC14A,C-type lectin domain family 14 member A,1741,50,3.23 [1.64-6.38],0.0007168291769065
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC3B,Tetranectin,1472,36,0.26 [0.09-0.77],0.0149822628832114
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC4A,C-type lectin domain family 4 member A,1726,49,0.47 [0.24-0.93],0.0309462997900147
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC5A,C-type lectin domain family 5 member A,1731,50,2.52 [1.15-5.53],0.0209859851808262
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLEC7A,C-type lectin domain family 7 member A,1751,50,2.14 [1.27-3.62],0.0043732956006157
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLMP,CXADR-like membrane protein,1751,50,8.07 [3.15-20.66],1.364182291580726e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLPS,Colipase,1739,50,0.74 [0.55-1.00],0.0491863440966938
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CLSTN1,Calsyntenin-1,1670,45,0.53 [0.30-0.94],0.0309226521277866
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CNTN5,Contactin-5,1732,49,0.39 [0.20-0.76],0.0053471209958023
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL18A1,Collagen alpha-1(XVIII) chain,1734,48,8.44 [3.51-20.29],1.8680940700422911e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL24A1,Collagen alpha-1(XXIV) chain,1487,38,2.28 [1.27-4.11],0.0059796014239083
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A1,Collagen alpha-1(IV) chain,1735,50,1.79 [1.07-2.99],0.0265893803291001
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL4A4,Collagen alpha-4(IV) chain,1479,38,0.53 [0.33-0.86],0.0096347444743509
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COL6A3,Collagen alpha-3(VI) chain,1753,50,3.94 [2.44-6.35],2.087767734352021e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,COLEC12,Collectin-12,1726,49,5.65 [2.85-11.22],7.373119937555236e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CPM,Carboxypeptidase M,1739,49,2.04 [1.04-3.97],0.0371773428420514
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRELD1,Protein disulfide isomerase CRELD1,1479,37,2.06 [1.03-4.11],0.040596758886557
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRH,Corticoliberin,1678,45,0.73 [0.53-1.00],0.0482993481386632
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CRIP2,Cysteine-rich protein 2,1718,47,2.11 [1.25-3.54],0.0050840076334963
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSF1,Macrophage colony-stimulating factor 1,1738,49,2.55 [1.18-5.54],0.0178422395829031
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST1,Cystatin-SN,1323,30,0.66 [0.45-0.96],0.0284649165491251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CST3,Cystatin-C,1736,49,3.61 [1.92-6.79],7.030861532850263e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CSTB,Cystatin-B,1708,50,1.87 [1.09-3.20],0.0232983084145591
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRC,Chymotrypsin-C,1726,49,0.67 [0.49-0.91],0.0095779019151714
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTRL,Chymotrypsin-like protease CTRL-1,1497,38,0.62 [0.42-0.92],0.0176617908855126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSE,Cathepsin E,1479,37,1.95 [1.15-3.30],0.0125215868826394
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSF,Cathepsin F,1741,50,2.63 [1.54-4.47],0.0003765033931737
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSS,Cathepsin S,1353,41,3.94 [1.14-13.67],0.0306944026300283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CTSZ,Cathepsin Z,1738,49,4.01 [2.01-8.01],8.217941176979093e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CX3CL1,Fractalkine,1718,47,2.94 [1.63-5.31],0.0003368308951908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL11,C-X-C motif chemokine 11,1748,49,1.34 [1.01-1.78],0.0412612622136328
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL16,C-X-C motif chemokine 16,1750,50,3.10 [1.31-7.37],0.0103288466385962
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL8,Interleukin-8,1721,50,1.37 [1.05-1.77],0.0187186675949047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,CXCL9,C-X-C motif chemokine 9,1738,49,1.51 [1.14-2.01],0.0046763452552652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",1741,50,2.99 [1.64-5.48],0.0003759279042482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DCN,Decorin,1701,48,5.15 [2.03-13.11],0.000579265158211
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",1733,49,1.82 [1.09-3.03],0.0219759071645579
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX25,ATP-dependent RNA helicase DDX25,1465,37,1.62 [1.07-2.45],0.0218645494618401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DDX53,Probable ATP-dependent RNA helicase DDX53,1465,37,0.37 [0.16-0.88],0.0234232779898143
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DEFB116,Beta-defensin 116,1441,37,1.35 [1.03-1.77],0.030485124210986
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DGCR6,Protein DGCR6,1441,37,1.75 [1.07-2.86],0.0258675690251441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DKK4,Dickkopf-related protein 4,1717,47,2.85 [1.91-4.25],2.812567584583705e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DLL1,Delta-like protein 1,1741,50,3.27 [1.75-6.11],0.0001970567053471
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DMP1,Dentin matrix acidic phosphoprotein 1,1469,38,0.55 [0.38-0.81],0.0022956642224912
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DOC2B,Double C2-like domain-containing protein beta,1465,37,0.37 [0.15-0.89],0.0269018706185765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DPP6,Dipeptidyl aminopeptidase-like protein 6,1733,49,3.18 [1.66-6.12],0.0005082482584186
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DRAXIN,Draxin,1718,47,2.07 [1.19-3.63],0.0106007627477898
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSC2,Desmocollin-2,1722,49,2.10 [1.42-3.11],0.0002207418582979
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,DSG4,Desmoglein-4,1725,49,0.38 [0.23-0.61],5.940250518741509e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDA2R,Tumor necrosis factor receptor superfamily member 27,1751,50,3.49 [2.29-5.31],5.950406719782148e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EDN1,Endothelin-1,1469,38,3.48 [1.33-9.08],0.0110284631094118
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFCAB14,EF-hand calcium-binding domain-containing protein 14,1487,38,3.36 [1.49-7.59],0.0034825295482492
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,1740,49,2.39 [1.21-4.73],0.0122618167649427
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFHD1,EF-hand domain-containing protein D1,1506,38,2.26 [1.21-4.23],0.0106730623117045
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA1,Ephrin-A1,1740,50,4.39 [2.41-8.01],1.3771281745928886e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EFNA4,Ephrin-A4,1715,47,5.77 [3.31-10.04],5.891906511632281e-10
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ELN,Elastin,1502,38,2.76 [1.35-5.64],0.0053578252949722
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,1701,48,3.29 [1.11-9.77],0.0319407718628626
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHA2,Ephrin type-A receptor 2,1674,45,3.19 [1.96-5.20],2.972125937758258e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB4,Ephrin type-B receptor 4,1753,50,2.82 [1.41-5.63],0.0032767560293145
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPHB6,Ephrin type-B receptor 6,1714,47,2.28 [1.14-4.55],0.0192684481807927
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,EPO,Erythropoietin,1726,49,1.37 [1.06-1.77],0.014957293261233
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESAM,Endothelial cell-selective adhesion molecule,1753,50,2.42 [1.22-4.79],0.0113100203625314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ESPL1,Separin,1449,38,1.56 [1.06-2.30],0.0225387588554538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP1,"Fatty acid-binding protein, liver",1726,49,1.43 [1.13-1.80],0.0024025316360756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP2,"Fatty acid-binding protein, intestinal",1735,50,1.47 [1.11-1.95],0.0080680826345764
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP3,"Fatty acid-binding protein, heart",1502,38,2.53 [1.63-3.93],3.786242962031127e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP4,"Fatty acid-binding protein, adipocyte",1753,50,2.00 [1.44-2.77],3.847964791952915e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FABP5,Fatty acid-binding protein 5,1746,49,1.41 [1.01-1.98],0.0454217555694607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3B,Protein FAM3B,1733,49,2.79 [1.53-5.09],0.000836036998908
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3C,Protein FAM3C,1735,50,4.63 [2.52-8.52],8.518761633723268e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FAM3D,Protein FAM3D,1487,38,1.63 [1.13-2.35],0.0086049726314785
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCER2,Low affinity immunoglobulin epsilon Fc receptor,1741,50,1.65 [1.05-2.59],0.0283720897287288
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,1682,45,0.60 [0.38-0.95],0.0310000745784942
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FCN1,Ficolin-1,1510,38,2.24 [1.16-4.30],0.0157149496088761
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF21,Fibroblast growth factor 21,1746,50,1.47 [1.22-1.77],5.666312984416589e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF23,Fibroblast growth factor 23,1748,50,1.68 [1.30-2.18],7.375218286938054e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGF5,Fibroblast growth factor 5,1687,47,3.71 [1.87-7.38],0.0001820454636888
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFBP1,Fibroblast growth factor-binding protein 1,1741,50,0.32 [0.16-0.64],0.0012053274001245
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGFR2,Fibroblast growth factor receptor 2,1741,50,4.11 [1.77-9.50],0.0009692356739092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FGL1,Fibrinogen-like protein 1,1511,38,2.06 [1.30-3.29],0.002304068143052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,1718,47,3.17 [1.60-6.28],0.0009103839112423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FLT1,Vascular endothelial growth factor receptor 1,1730,49,2.48 [1.08-5.73],0.0328864335825374
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FOLR1,Folate receptor alpha,1732,50,2.14 [1.01-4.55],0.0475320444148617
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FSTL3,Follistatin-related protein 3,1727,49,2.37 [1.30-4.32],0.0048064868842363
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUCA1,Tissue alpha-L-fucosidase,1747,50,1.41 [1.00-1.99],0.0487904158559573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,1748,49,1.80 [1.11-2.92],0.0175919163015049
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,1733,49,2.82 [1.27-6.28],0.0108554536421477
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GCG,Pro-glucagon,1682,45,1.26 [1.03-1.54],0.0261605285707263
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GDF15,Growth/differentiation factor 15,1753,50,2.39 [1.70-3.37],5.837293344705847e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA1,GDNF family receptor alpha-1,1746,50,5.26 [2.68-10.33],1.3633516707825678e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GFRA3,GDNF family receptor alpha-3,1712,47,2.56 [1.18-5.54],0.0172331486924401
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GGT5,Glutathione hydrolase 5 proenzyme,1718,47,5.31 [2.15-13.10],0.0002912855046904
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GIPC2,PDZ domain-containing protein GIPC2,1497,38,2.96 [1.26-6.98],0.0128875781792909
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GLA,Alpha-galactosidase A,1475,37,2.32 [1.15-4.70],0.0189882996342027
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPA33,Cell surface A33 antigen,1733,49,0.76 [0.62-0.94],0.0097114912312993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPR37,Prosaposin receptor GPR37,1701,48,2.02 [1.43-2.87],7.688395197291649e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GPRC5C,G-protein coupled receptor family C group 5 member C,1498,38,1.43 [1.04-1.97],0.0267888719889641
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRK5,G protein-coupled receptor kinase 5,1701,48,0.46 [0.23-0.92],0.028569600438546
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GRN,Progranulin,1734,50,3.71 [1.36-10.08],0.0102215125666662
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GSAP,Gamma-secretase-activating protein,1682,45,0.57 [0.34-0.96],0.0329572657392167
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,GUCA2A,Guanylin,1733,50,2.51 [1.51-4.16],0.0003721669507765
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR1,Hepatitis A virus cellular receptor 1,1749,50,1.87 [1.45-2.42],1.5295641117890807e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HAVCR2,Hepatitis A virus cellular receptor 2,1741,50,2.49 [1.37-4.52],0.0027702811226417
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HBZ,Hemoglobin subunit zeta,1502,38,0.71 [0.51-0.99],0.0431983944158816
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HEG1,Protein HEG homolog 1,1479,37,2.83 [1.02-7.85],0.0462585952442676
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",1506,38,3.61 [1.31-10.00],0.0133847641054952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",1726,49,2.93 [1.47-5.83],0.0022433811726295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX1,Heme oxygenase 1,1724,50,0.52 [0.31-0.87],0.013124337022371
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HMOX2,Heme oxygenase 2,1670,45,1.58 [1.01-2.48],0.0456915328082872
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HNMT,Histamine N-methyltransferase,1710,47,1.57 [1.01-2.44],0.0453868022892861
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPB6,Heat shock protein beta-6,1751,50,2.98 [1.79-4.94],2.474817293640529e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,1726,47,4.11 [2.22-7.62],7.04036644228124e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,HYAL1,Hyaluronidase-1,1720,48,3.25 [1.32-7.97],0.010177253572015
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ICAM4,Intercellular adhesion molecule 4,1726,49,0.62 [0.40-0.98],0.0411821478241327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGF1R,Insulin-like growth factor 1 receptor,1733,49,7.26 [2.53-20.87],0.0002321037785482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP1,Insulin-like growth factor-binding protein 1,1751,50,1.48 [1.21-1.82],0.0001809719487581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP2,Insulin-like growth factor-binding protein 2,1751,50,1.72 [1.25-2.38],0.0008425786409559
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP3,Insulin-like growth factor-binding protein 3,1743,49,0.46 [0.27-0.81],0.006493210481948
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP4,Insulin-like growth factor-binding protein 4,1716,48,2.29 [1.59-3.30],7.558887978147263e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP6,Insulin-like growth factor-binding protein 6,1734,48,2.96 [1.66-5.29],0.0002448840089316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBP7,Insulin-like growth factor-binding protein 7,1753,50,2.08 [1.14-3.78],0.0165551714008775
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGFBPL1,Insulin-like growth factor-binding protein-like 1,1735,50,2.48 [1.49-4.13],0.000505239152175
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF8,Immunoglobulin superfamily member 8,1735,50,2.44 [1.14-5.23],0.0213307912537032
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IGSF9,Protein turtle homolog A,1502,38,1.59 [1.16-2.17],0.0037174504870931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10,Interleukin-10,1687,47,1.30 [1.05-1.61],0.0164840142462077
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL10RB,Interleukin-10 receptor subunit beta,1738,49,2.48 [1.22-5.05],0.012524875548246
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12A_IL12B,Interleukin-12,1733,49,1.37 [1.03-1.82],0.0279228110720535
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL12B,Interleukin-12 subunit beta,1751,50,1.61 [1.05-2.47],0.0299167409245849
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL15RA,Interleukin-15 receptor subunit alpha,1687,47,2.44 [1.21-4.93],0.0125923882423209
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL17D,Interleukin-17D,1687,47,1.69 [1.06-2.68],0.0266409269561554
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18,Interleukin-18,1724,49,1.80 [1.09-2.97],0.0224460765984656
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL18BP,Interleukin-18-binding protein,1743,49,2.15 [1.11-4.17],0.0232429625835025
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL19,Interleukin-19,1697,49,1.48 [1.11-1.96],0.0075934979136616
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL1RL1,Interleukin-1 receptor-like 1,1748,50,1.88 [1.16-3.05],0.0102457680960268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL20,Interleukin-20,1687,47,0.38 [0.19-0.76],0.0060124603406204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL2RA,Interleukin-2 receptor subunit alpha,1726,50,2.07 [1.24-3.44],0.005163373033038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IL5,Interleukin-5,1687,47,0.81 [0.66-0.99],0.0437573723466878
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,IMMT,MICOS complex subunit MIC60,1498,38,1.66 [1.06-2.60],0.0263580704196592
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBB,Inhibin beta B chain,1479,37,2.12 [1.30-3.47],0.0026961461582108
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INHBC,Inhibin beta C chain,1741,50,1.97 [1.01-3.84],0.0479742562927467
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",1506,38,2.01 [1.18-3.40],0.0096569575255113
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,INSR,Insulin receptor,1453,37,8.89 [1.67-47.42],0.0105226838024727
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITGA6,Integrin alpha-6,1726,49,0.58 [0.34-0.99],0.0469820608872168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,1743,49,1.95 [1.02-3.75],0.0442643303041161
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,JAM2,Junctional adhesion molecule B,1748,49,4.36 [2.32-8.22],5.032021727099544e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLB,Beta-klotho,1670,45,1.43 [1.02-2.00],0.037234141211581
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLF4,Krueppel-like factor 4,1441,37,2.48 [1.07-5.76],0.0345050430409472
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK10,Kallikrein-10,1734,50,2.12 [1.25-3.61],0.0055553539035423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK11,Kallikrein-11,1719,49,3.06 [1.78-5.27],5.552147188564511e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLK4,Kallikrein-4,1751,50,1.80 [1.33-2.44],0.0001287044068107
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRB1,Killer cell lectin-like receptor subfamily B member 1,1751,50,2.11 [1.23-3.63],0.0067177556320168
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRD1,Natural killer cells antigen CD94,1751,50,1.81 [1.09-2.99],0.0209121605797567
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KLRF1,Killer cell lectin-like receptor subfamily F member 1,1453,37,1.64 [1.07-2.51],0.024155259448984
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,KRT19,"Keratin, type I cytoskeletal 19",1721,49,1.53 [1.15-2.05],0.0036767797597447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAG3,Lymphocyte activation gene 3 protein,1733,49,1.81 [1.10-2.99],0.0204054847777268
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,1726,49,2.39 [1.65-3.45],3.987288918351566e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LAYN,Layilin,1714,47,4.03 [2.50-6.50],1.141648927688673e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN15,Lipocalin-15,1506,38,1.61 [1.14-2.27],0.0063931065827536
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LCN2,Neutrophil gelatinase-associated lipocalin,1686,48,1.78 [1.06-2.98],0.0295863828920252
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LECT2,Leukocyte cell-derived chemotaxin-2,1502,38,1.56 [1.08-2.25],0.0176738450750282
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LELP1,Late cornified envelope-like proline-rich protein 1,1441,37,0.56 [0.35-0.89],0.0145498112013624
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS1,Galectin-1,1735,50,2.12 [1.09-4.10],0.0261312038148442
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS3,Galectin-3,1732,50,2.55 [1.17-5.56],0.0181543749316396
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS4,Galectin-4,1726,49,2.14 [1.48-3.11],6.33371925794879e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LGALS9,Galectin-9,1728,49,2.50 [1.26-4.97],0.0085470898786755
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LIFR,Leukemia inhibitory factor receptor,1726,49,2.62 [1.20-5.72],0.0159392955114406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LMOD1,Leiomodin-1,1506,38,2.44 [1.31-4.57],0.0051975785501258
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LPO,Lactoperoxidase,1677,47,1.79 [1.28-2.49],0.0006027465860612
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,1744,50,2.11 [1.07-4.15],0.0316039331987937
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,1449,37,1.85 [1.01-3.38],0.0460419302113255
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRP11,Low-density lipoprotein receptor-related protein 11,1735,50,2.10 [1.18-3.74],0.0113894935715155
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LRRN1,Leucine-rich repeat neuronal protein 1,1687,47,0.43 [0.23-0.81],0.0092024823749105
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBP2,Latent-transforming growth factor beta-binding protein 2,1753,50,2.10 [1.12-3.92],0.0206486169529876
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LTBR,Tumor necrosis factor receptor superfamily member 3,1720,49,2.75 [1.47-5.15],0.0015629274481047
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY6D,Lymphocyte antigen 6D,1719,48,2.02 [1.25-3.28],0.0041519324963302
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,LY96,Lymphocyte antigen 96,1718,47,1.92 [1.03-3.59],0.0399896293534541
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MAMDC2,MAM domain-containing protein 2,1502,38,2.14 [1.05-4.38],0.0361581546815469
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MANSC1,MANSC domain-containing protein 1,1741,50,2.22 [1.03-4.81],0.041999470128294
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MB,Myoglobin,1753,50,1.55 [1.01-2.38],0.0443131180694475
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MDK,Midkine,1738,50,2.52 [1.64-3.88],2.664417745863904e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEGF11,Multiple epidermal growth factor-like domains protein 11,1448,37,2.05 [1.02-4.11],0.0437496865008851
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MELTF,Melanotransferrin,1502,38,2.68 [1.39-5.14],0.0030938481609192
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MEPE,Matrix extracellular phosphoglycoprotein,1726,49,0.41 [0.19-0.88],0.0218053140116487
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP4,Microfibril-associated glycoprotein 4,1479,37,2.40 [1.03-5.60],0.0428990942081712
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFAP5,Microfibrillar-associated protein 5,1753,50,2.39 [1.40-4.09],0.0015075561653129
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MFGE8,Lactadherin,1741,50,1.73 [1.15-2.59],0.0081199407382601
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP10,Stromelysin-2,1727,49,1.52 [1.05-2.20],0.0280307595627046
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP12,Macrophage metalloelastase,1737,50,1.90 [1.26-2.85],0.0021063504240896
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MMP7,Matrilysin,1699,48,1.71 [1.03-2.86],0.0398754946493768
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MOG,Myelin-oligodendrocyte glycoprotein,1751,50,2.32 [1.25-4.31],0.0075164276523902
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MRPL24,"39S ribosomal protein L24, mitochondrial",1448,37,1.54 [1.01-2.34],0.042483036852458
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSLNL,Mesothelin-like protein,1465,37,0.37 [0.14-0.98],0.045839991394997
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSR1,Macrophage scavenger receptor types I and II,1748,49,1.83 [1.08-3.09],0.025341623683919
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MSTN,Growth/differentiation factor 8,1701,48,0.57 [0.35-0.94],0.0267683889535549
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MUC13,Mucin-13,1670,45,1.74 [1.23-2.48],0.0019341579585795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",1465,37,1.84 [1.08-3.14],0.0244552227400104
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,1479,37,4.29 [1.17-15.76],0.0281641100229635
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NBL1,Neuroblastoma suppressor of tumorigenicity 1,1741,50,4.62 [2.25-9.49],3.087259715149018e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR1,Natural cytotoxicity triggering receptor 1,1726,49,2.88 [1.63-5.09],0.0002880943795321
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,1487,38,3.79 [1.79-8.03],0.0004910057482289
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NCS1,Neuronal calcium sensor 1,1751,50,4.28 [2.03-9.02],0.0001364081543723
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NDRG1,Protein NDRG1,1670,45,1.29 [1.00-1.65],0.0478577391301762
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN2,Nectin-2,1735,50,2.91 [1.54-5.51],0.0010226188720993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NECTIN4,Nectin-4,1741,50,2.43 [1.60-3.68],2.7924678495367504e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NEFL,Neurofilament light polypeptide,1665,45,3.69 [2.52-5.40],1.879371469853093e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NELL1,Protein kinase C-binding protein NELL1,1741,50,0.32 [0.21-0.50],4.013679445009887e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NFASC,Neurofascin,1751,50,2.60 [1.28-5.29],0.0080576130331369
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NGF,Beta-nerve growth factor,1718,47,14.10 [1.55-128.04],0.0187021054860756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOMO1,Nodal modulator 1,1741,50,2.21 [1.05-4.68],0.0375787657753218
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOS1,"Nitric oxide synthase, brain",1670,45,2.19 [1.40-3.42],0.0005537692286654
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NOTCH2,Neurogenic locus notch homolog protein 2,1508,38,3.38 [1.13-10.11],0.0291881977541309
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPC2,NPC intracellular cholesterol transporter 2,1491,37,3.93 [1.72-9.00],0.0011969590406283
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPDC1,Neural proliferation differentiation and control protein 1,1735,50,2.62 [1.61-4.28],0.0001175969905447
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NPY,Pro-neuropeptide Y,1751,50,1.71 [1.16-2.52],0.0066454501344573
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NRP1,Neuropilin-1,1744,49,2.28 [1.02-5.10],0.0436798887994231
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NT5C1A,Cytosolic 5'-nucleotidase 1A,1497,38,2.04 [1.12-3.71],0.0196319926318756
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NTproBNP,N-terminal prohormone of brain natriuretic peptide,1735,50,1.41 [1.16-1.71],0.0005218387785531
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NUCB2,Nucleobindin-2,1750,50,2.06 [1.10-3.87],0.0237186694714744
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,NXPH1,Neurexophilin-1,1670,45,1.91 [1.17-3.12],0.0094644258425794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OCLN,Occludin,1506,38,1.85 [1.03-3.35],0.0410861148747482
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OGN,Mimecan,1741,50,3.34 [2.15-5.21],9.455415034334e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,OPTC,Opticin,1733,49,1.90 [1.17-3.08],0.009765638961343
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM,Paralemmin-1,1479,37,2.26 [1.04-4.91],0.0393113518276441
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PALM2,Paralemmin-2,1497,38,2.91 [1.58-5.36],0.0005818497485042
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH1,Protocadherin-1,1745,50,2.41 [1.16-5.00],0.0187716053112251
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PCDH7,Protocadherin-7,1487,38,1.80 [1.14-2.83],0.011480521631693
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1,Programmed cell death protein 1,1749,49,1.68 [1.14-2.46],0.0080722843800795
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDCD1LG2,Programmed cell death 1 ligand 2,1733,49,3.11 [1.46-6.61],0.0031896648178159
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PDGFRA,Platelet-derived growth factor receptor alpha,1735,50,2.50 [1.16-5.41],0.0199371541860607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PGF,Placenta growth factor,1751,50,3.26 [1.65-6.46],0.0006907178427651
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,1718,47,4.68 [2.17-10.08],8.310911363657527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PI3,Elafin,1714,50,1.72 [1.24-2.40],0.0012339285931957
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIGR,Polymeric immunoglobulin receptor,1720,50,2.51 [1.47-4.31],0.000800755509584
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,1741,50,5.20 [2.99-9.06],5.694332442333567e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRA,Paired immunoglobulin-like type 2 receptor alpha,1741,50,2.63 [1.44-4.81],0.0016943238586141
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PILRB,Paired immunoglobulin-like type 2 receptor beta,1735,50,1.83 [1.15-2.94],0.0113964985717494
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PKD1,Polycystin-1,1502,38,4.86 [1.60-14.78],0.0053143507068856
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLA2G7,Platelet-activating factor acetylhydrolase,1741,50,0.35 [0.20-0.64],0.0005039485525195
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLAUR,Urokinase plasminogen activator surface receptor,1719,49,3.47 [1.63-7.40],0.001234418015885
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLB1,"Phospholipase B1, membrane-associated",1497,38,0.43 [0.25-0.72],0.0015093558654526
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLTP,Phospholipid transfer protein,1747,50,0.55 [0.30-1.00],0.0482886887916931
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PLXNB2,Plexin-B2,1741,50,4.81 [2.27-10.21],4.291932317356884e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POF1B,Protein POF1B,1453,37,1.80 [1.10-2.94],0.0188203250370625
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",1733,49,1.89 [1.17-3.06],0.0089875569967987
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON2,Serum paraoxonase/arylesterase 2,1701,48,0.45 [0.22-0.91],0.02545545521316
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PON3,Serum paraoxonase/lactonase 3,1738,49,0.48 [0.24-0.97],0.0415744992294177
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRAP1,Proline-rich acidic protein 1,1508,38,5.89 [2.65-13.12],1.4194009507922664e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRELP,Prolargin,1726,49,3.34 [1.28-8.72],0.0139087716439828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRL,Prolactin,1748,49,1.56 [1.23-1.98],0.0002319502417406
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRR4,Proline-rich protein 4,1464,36,1.65 [1.09-2.52],0.0192339019168973
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS27,Serine protease 27,1731,50,2.13 [1.19-3.82],0.0109534291288219
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRSS8,Prostasin,1728,49,2.20 [1.30-3.75],0.0034472504889238
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PRTG,Protogenin,1751,50,2.45 [1.07-5.61],0.0336041337251793
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSAP,Prosaposin,1499,38,4.78 [1.75-13.05],0.0022812095936126
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PSG1,Pregnancy-specific beta-1-glycoprotein 1,1718,47,1.51 [1.20-1.90],0.0005192610389079
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTGDS,Prostaglandin-H2 D-isomerase,1724,48,3.83 [2.19-6.71],2.587545286233928e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTK7,Inactive tyrosine-protein kinase 7,1670,45,3.17 [1.73-5.81],0.0001855198718052
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,1713,47,2.55 [1.57-4.16],0.0001566313251731
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PVR,Poliovirus receptor,1748,49,1.85 [1.04-3.30],0.0361089014742453
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXDNL,Peroxidasin-like protein,1498,38,1.51 [1.11-2.06],0.0088023912441413
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PXN,Paxillin,1670,45,1.64 [1.10-2.44],0.0153590300396687
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,PYY,Peptide YY,1448,37,1.45 [1.13-1.85],0.0036815587900424
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RAB6A,Ras-related protein Rab-6A,1726,49,0.43 [0.26-0.72],0.0011277906128846
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RARRES2,Retinoic acid receptor responder protein 2,1744,49,1.89 [1.16-3.09],0.0107498114953455
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBFOX3,RNA binding protein fox-1 homolog 3,1506,38,1.81 [1.17-2.79],0.0071859459267981
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP2,Retinol-binding protein 2,1733,49,1.67 [1.23-2.28],0.0011555530878503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RBP7,Retinoid-binding protein 7,1487,38,1.55 [1.08-2.22],0.0171352605846259
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1A,Lithostathine-1-alpha,1730,48,1.87 [1.33-2.62],0.0002711016034757
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG1B,Lithostathine-1-beta,1753,50,1.44 [1.05-1.98],0.0231101991151088
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REG4,Regenerating islet-derived protein 4,1730,49,2.51 [1.73-3.64],1.4234728445821545e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RELT,Tumor necrosis factor receptor superfamily member 19L,1741,50,3.33 [1.71-6.50],0.0004173515856746
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,REN,Renin,1735,50,1.49 [1.20-1.86],0.0003618491320191
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RGMB,RGM domain family member B,1748,49,2.39 [1.10-5.18],0.0275675427652322
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,1448,37,1.49 [1.08-2.05],0.0140878470803515
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE1,Ribonuclease pancreatic,1511,38,3.86 [1.53-9.72],0.0041204255670452
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE4,Ribonuclease 4,1455,38,3.56 [1.27-9.93],0.0154471301737809
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASE6,Ribonuclease K6,1497,37,2.50 [1.21-5.20],0.0138198248026745
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNASET2,Ribonuclease T2,1747,50,2.48 [1.55-3.96],0.0001448548847196
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RNF149,E3 ubiquitin-protein ligase RNF149,1469,38,3.51 [1.63-7.56],0.0013761693504576
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RSPO3,R-spondin-3,1751,50,2.67 [1.36-5.24],0.0043428932634299
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,RTN4R,Reticulon-4 receptor,1751,50,2.36 [1.16-4.81],0.0178452303559645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,S100P,Protein S100-P,1701,48,1.65 [1.21-2.26],0.0015276194609314
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARA5,Scavenger receptor class A member 5,1748,49,5.25 [2.89-9.54],5.27779183570103e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARB2,Lysosome membrane protein 2,1680,46,3.38 [2.04-5.63],2.570322189774244e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCARF2,Scavenger receptor class F member 2,1748,49,4.89 [2.43-9.85],9.024179437501008e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG2,Secretogranin-2,1743,50,3.62 [1.98-6.63],2.976894329702498e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCG3,Secretogranin-3,1730,49,2.13 [1.06-4.28],0.0331741550521815
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGB1A1,Uteroglobin,1735,49,1.97 [1.24-3.15],0.0043977307764901
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCGN,Secretagogin,1687,47,2.80 [1.78-4.40],8.26642881481056e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SCRG1,Scrapie-responsive protein 1,1502,38,2.83 [1.17-6.86],0.0215402848677055
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SEPTIN3,Neuronal-specific septin-3,1506,38,0.61 [0.40-0.95],0.0293776517959423
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPIND1,Heparin cofactor 2,1508,37,3.60 [1.19-10.95],0.0238662850668327
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPINF1,Pigment epithelium-derived factor,1482,37,3.00 [1.05-8.56],0.0401198530298512
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SERPING1,Plasma protease C1 inhibitor,1508,37,7.05 [1.41-35.33],0.0175460603002739
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SFRP1,Secreted frizzled-related protein 1,1714,47,2.01 [1.24-3.25],0.0046474979864217
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SHISA5,Protein shisa-5,1508,38,3.84 [1.79-8.22],0.0005411551050615
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SIT1,Signaling threshold-regulating transmembrane adapter 1,1687,47,1.59 [1.02-2.48],0.0417451799993038
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLC39A14,Zinc transporter ZIP14,1670,45,1.73 [1.18-2.53],0.0045968049882555
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SLITRK6,SLIT and NTRK-like protein 6,1701,48,2.30 [1.17-4.55],0.0160602241987994
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMARCA2,Probable global transcription activator SNF2L2,1670,45,1.46 [1.11-1.92],0.0066857308280658
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC1,SPARC-related modular calcium-binding protein 1,1751,50,3.29 [1.61-6.73],0.0011171212099082
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMOC2,SPARC-related modular calcium-binding protein 2,1738,49,2.14 [1.30-3.51],0.0025976050504285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SMPD1,Sphingomyelin phosphodiesterase,1736,49,1.61 [1.00-2.59],0.0493306757513609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SNCG,Gamma-synuclein,1718,47,1.91 [1.36-2.67],0.0001655235394771
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SORCS2,VPS10 domain-containing receptor SorCS2,1682,45,2.77 [1.50-5.13],0.0011706110394719
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPESP1,Sperm equatorial segment protein 1,1502,38,2.86 [1.06-7.68],0.0372504248610743
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK1,Serine protease inhibitor Kazal-type 1,1741,50,1.91 [1.37-2.66],0.000140280774206
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPINK4,Serine protease inhibitor Kazal-type 4,1726,49,2.54 [1.88-3.43],1.190458829849791e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SPON2,Spondin-2,1729,49,2.80 [1.59-4.94],0.0003652787812564
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",1733,49,1.88 [1.12-3.15],0.0168032040188213
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",1453,37,1.69 [1.12-2.55],0.0122202251496562
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,STC1,Stanniocalcin-1,1748,49,2.31 [1.42-3.74],0.0006800799417645
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,SV2A,Synaptic vesicle glycoprotein 2A,1465,37,0.44 [0.24-0.80],0.007477165364824
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TAFA5,Chemokine-like protein TAFA-5,1733,49,2.71 [1.67-4.42],5.986425566401445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TCN2,Transcobalamin-2,1751,50,2.18 [1.29-3.71],0.0037569679473102
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TDO2,"Tryptophan 2,3-dioxygenase",1465,37,0.32 [0.11-0.96],0.041180078763778
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF1,Trefoil factor 1,1733,50,1.65 [1.30-2.09],4.5933792408612856e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF2,Trefoil factor 2,1733,49,2.20 [1.59-3.04],1.986141871469732e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFF3,Trefoil factor 3,1725,49,2.11 [1.53-2.90],5.659875097370885e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TFPI2,Tissue factor pathway inhibitor 2,1736,50,1.55 [1.08-2.24],0.0174380652731223
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBI,Transforming growth factor-beta-induced protein ig-h3,1729,48,0.37 [0.15-0.88],0.0247690378609285
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR2,TGF-beta receptor type-2,1741,50,2.71 [1.74-4.24],1.1447827943001576e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TGFBR3,Transforming growth factor beta receptor type 3,1753,50,2.13 [1.11-4.09],0.0232297058414582
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THBS2,Thrombospondin-2,1741,50,1.59 [1.06-2.39],0.0242327182647993
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,THY1,Thy-1 membrane glycoprotein,1748,49,2.95 [1.46-5.95],0.0024642329797607
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMEM25,Transmembrane protein 25,1506,38,1.72 [1.04-2.85],0.035492380959228
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS11D,Transmembrane protease serine 11D,1495,37,2.06 [1.17-3.63],0.0119742939826652
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS15,Enteropeptidase,1733,49,1.32 [1.00-1.75],0.049741370248204
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TMPRSS5,Transmembrane protease serine 5,1710,47,1.98 [1.00-3.94],0.0498797857442794
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,1718,47,5.16 [2.62-10.14],2.0307159629440165e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,1718,47,1.53 [1.24-1.88],5.050207724671718e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,1751,50,2.65 [1.68-4.17],2.795659065906033e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,1726,49,1.96 [1.02-3.75],0.0425785023944609
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,1741,50,3.32 [2.00-5.52],3.391872905635034e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,1730,49,3.52 [2.01-6.17],1.088906751613951e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,1751,50,2.87 [1.76-4.68],2.429399649540302e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,1741,50,3.43 [1.86-6.31],7.775303313408917e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,1741,50,1.66 [1.20-2.28],0.0019585702000708
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,1748,49,3.32 [1.50-7.35],0.0030859344373127
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,1749,50,2.43 [1.50-3.94],0.0003234765974092
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,1718,47,2.14 [1.43-3.19],0.0002012817880162
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,1748,49,1.67 [1.10-2.52],0.0152790930488305
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,1718,47,2.70 [1.71-4.28],2.2593002165648105e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF13,Tumor necrosis factor ligand superfamily member 13,1738,49,5.35 [2.47-11.56],2.0070506992801443e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TNFSF8,Tumor necrosis factor ligand superfamily member 8,1508,38,2.33 [1.13-4.83],0.0221585813970539
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TPPP3,Tubulin polymerization-promoting protein family member 3,1670,45,1.45 [1.02-2.07],0.0395571487687538
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",1453,37,2.42 [1.36-4.31],0.0026184197531503
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ULBP2,UL16-binding protein 2,1718,47,3.44 [1.98-5.97],1.0894160713255728e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,UMOD,Uromodulin,1747,50,0.31 [0.22-0.44],2.8540815124170888e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFB,Vascular endothelial growth factor B,1453,37,3.41 [1.28-9.09],0.0140731711431357
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VEGFD,Vascular endothelial growth factor D,1749,50,2.42 [1.29-4.54],0.0059878605020683
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VMO1,Vitelline membrane outer layer protein 1 homolog,1733,49,1.78 [1.18-2.68],0.0056627697652736
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG2,V-set and immunoglobulin domain-containing protein 2,1498,38,1.87 [1.32-2.66],0.0004397073926295
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VSIG4,V-set and immunoglobulin domain-containing protein 4,1737,48,2.34 [1.44-3.80],0.0005809144310844
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,VWC2,Brorin,1711,47,3.34 [1.86-5.99],5.442865153012694e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WASL,Neural Wiskott-Aldrich syndrome protein,1453,37,1.37 [1.01-1.88],0.0460769606054696
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC12,WAP four-disulfide core domain protein 12,1749,50,1.60 [1.15-2.22],0.0050736439296828
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFDC2,WAP four-disulfide core domain protein 2,1652,47,2.80 [1.92-4.06],6.897629155023066e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",1711,47,0.52 [0.29-0.95],0.0344690552187952
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,WNT9A,Protein Wnt-9a,1687,47,1.82 [1.12-2.96],0.0159153201005969
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,XG,Glycoprotein Xg,1743,50,3.39 [1.99-5.76],6.890317708476241e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,YAP1,Transcriptional coactivator YAP1,1497,38,3.15 [1.31-7.55],0.0103094458765158
"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,ZP3,Zona pellucida sperm-binding protein 3,1469,38,1.15 [1.01-1.31],0.0397213677370909
